
AN2 Therapeutics, Inc.
ANTXHealthcare|Biotechnology|US
$4.00
+0.04 (+1.14%)
DCF Value
$0.59
Tangible Book / Share
$1.70
Cash / Share
$1.75
Ownership Breakdown
59.1%
Float
37.7M
Shares Outstanding
22.3M
Float Shares
Major Holders (25)
Combined: 168.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Commodore Capital LP | IA, PN | 9.90% | 3,697,435 | Mar 16, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 9.90% | 3,697,435 | Mar 16, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 9.90% | 3,697,435 | Mar 16, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 9.90% | 3,697,435 | Mar 16, 2026 | 13D/G |
| Coastlands Capital LLC | HC, OO | 9.30% | 2,815,900 | Jun 4, 2025 | 13D/G |
| Coastlands Capital GP LLC | Other | 9.30% | 2,815,900 | Jun 4, 2025 | 13D/G |
| Coastlands Capital LP | IA, PN | 9.30% | 2,815,900 | Jun 4, 2025 | 13D/G |
| Matthew D. Perry | HC, IN | 9.30% | 2,815,900 | Jun 4, 2025 | 13D/G |
| Coastlands Capital Partners LP | Partnership | 9.30% | 2,815,900 | Jun 4, 2025 | 13D/G |
| Vivo Opportunity, LLC | Other | 8.00% | 2,864,346 | Mar 13, 2026 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 8.00% | 2,864,346 | Mar 13, 2026 | 13D/G |
| Eric Easom | Individual | 7.90% | 2,232,004 | Feb 13, 2026 | 13D/G |
| Adjuvant Capital GP, L.P. | Other | 7.90% | 2,373,500 | Feb 28, 2025 | 13D/G |
| Adjuvant Capital Management, L.L.C. | Other | 7.90% | 2,373,500 | Feb 28, 2025 | 13D/G |
| Adjuvant Global Health Technology Fund, L.P. | Partnership | 6.70% | 1,995,958 | Feb 28, 2025 | 13D/G |
| Millennium Group Management LLC | Other | 6.30% | 2,237,102 | Mar 13, 2026 | 13D/G |
| Millennium Management LLC | Other | 6.30% | 2,237,102 | Mar 13, 2026 | 13D/G |
| Israel A. Englander | Individual | 6.30% | 2,237,102 | Mar 13, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 6.00% | 2,135,044 | Mar 13, 2026 | 13D/G |
| Almitas Capital LLC | Investment adviser | 4.10% | 1,479,129 | May 15, 2026 | 13D/G |
| Brii Biosciences Limited | Corporation | 3.10% | 927,201 | Feb 14, 2025 | 13D/G |
| BML Investment Partners, L.P. | Partnership | 1.40% | 427,432 | Jun 18, 2025 | 13D/G |
| Adjuvant Global Health Technology Fund DE, L.P. | Partnership | 1.30% | 377,542 | Feb 28, 2025 | 13D/G |
| Vivo Opportunity Cayman, LLC | Other | 0.80% | 289,294 | Mar 13, 2026 | 13D/G |
| Vivo Opportunity Cayman Fund, L.P. | Partnership | 0.80% | 289,294 | Mar 13, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 3,005,480 acquired · 2,349,519 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Eizen Joshua M | See Remarks | Nov 5, 2026 | SELL | 2,826 | $4.22 | $11.9K | Form 4 |
| Marks Gilbert Lynn | director | Oct 12, 2026 | AWARD | 2,283 | — | — | Form 4 |
| Martin Patricia A. | director | Oct 12, 2026 | AWARD | 389 | — | — | Form 4 |
| Aziz Kabeer | director | Oct 12, 2026 | AWARD | 2,465 | — | — | Form 4 |
| Trenor Cameron C. III | Chief Medical Officer | Sep 15, 2026 | AWARD | 233,333 | $5.36 | $1.3M | Form 4 |
| Trenor Cameron C. III | Chief Medical Officer | Sep 15, 2026 | AWARD | 116,667 | — | — | Form 4 |
| Readnour Robin Shane | director | Sep 9, 2026 | SELL | 585 | $6.02 | $3.5K | Form 4 |
| Readnour Robin Shane | director | Sep 9, 2026 | SELL | 523 | $6.02 | $3.2K | Form 4 |
| Readnour Robin Shane | director | Sep 3, 2026 | SELL | 3,223 | $6.07 | $19.6K | Form 4 |
| Readnour Robin Shane | director | Sep 8, 2026 | SELL | 5,294 | $6.02 | $31.9K | Form 4 |
| Readnour Robin Shane | director | Sep 3, 2026 | SELL | 2,877 | $6.07 | $17.5K | Form 4 |
| Readnour Robin Shane | director | Sep 8, 2026 | SELL | 4,725 | $6.02 | $28.4K | Form 4 |
| Williams Sarah Joanne | Principal Accounting Officer | Sep 1, 2026 | SELL | 272 | $5.53 | $1.5K | Form 4 |
| FitzPatrick Margaret M | director | Sep 1, 2026 | BUY | 2,098 | $5.53 | $11.6K | Form 4 |
| Trenor Cameron C. III | Aug 24, 2026 | OTHER | 0 | — | — | Form 4 | |
| Readnour Robin Shane | director | Aug 17, 2026 | SELL | 18,706 | $6.01 | $112.4K | Form 4 |
| Readnour Robin Shane | director | Aug 17, 2026 | SELL | 16,696 | $6.01 | $100.3K | Form 4 |
| Zakrzewski Joseph S | director | Aug 14, 2026 | GIFT | 405,880 | — | — | Form 4 |
| Aziz Kabeer | director | Jul 10, 2026 | AWARD | 2,852 | — | — | Form 4 |
| Marks Gilbert Lynn | director | Jul 10, 2026 | AWARD | 2,789 | — | — | Form 4 |
| Martin Patricia A. | director | Jul 10, 2026 | AWARD | 766 | — | — | Form 4 |
| Eizen Joshua M | See Remarks | Jul 8, 2026 | SELL | 5,945 | $4.17 | $24.8K | Form 4 |
| Williams Sarah Joanne | Principal Accounting Officer | May 29, 2026 | SELL | 265 | $4.43 | $1.2K | Form 4 |
| Aziz Kabeer | director | Apr 10, 2026 | AWARD | 3,775 | — | — | Form 4 |
| Marks Gilbert Lynn | director | Apr 10, 2026 | AWARD | 3,775 | — | — | Form 4 |
| Martin Patricia A. | director | Apr 10, 2026 | AWARD | 1,192 | — | — | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | AWARD | 82,300 | $3.91 | $321.8K | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | AWARD | 73,665 | $3.91 | $288.0K | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | AWARD | 66,000 | $3.91 | $258.1K | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | DISPOSED | 66,000 | $17.28 | $1.1M | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | DISPOSED | 73,665 | $6.60 | $485.9K | Form 4 |
| Day Lucy | Chief Financial Officer | Mar 19, 2026 | DISPOSED | 82,300 | $14.29 | $1.2M | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | AWARD | 66,000 | $3.91 | $258.1K | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | AWARD | 57,950 | $3.91 | $226.6K | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | AWARD | 41,665 | $3.91 | $162.9K | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | DISPOSED | 66,000 | $17.28 | $1.1M | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | DISPOSED | 57,950 | $14.29 | $828.1K | Form 4 |
| Chanda Sanjay | Chief Development Officer | Mar 19, 2026 | DISPOSED | 41,665 | $6.60 | $274.8K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | AWARD | 10,665 | $3.91 | $41.7K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | DISPOSED | 10,665 | $6.60 | $70.3K | Form 4 |
| Marks Gilbert Lynn | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Aziz Kabeer | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Aziz Kabeer | director | Mar 19, 2026 | AWARD | 20,724 | $3.91 | $81.0K | Form 4 |
| Aziz Kabeer | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Aziz Kabeer | director | Mar 19, 2026 | DISPOSED | 20,724 | $17.28 | $358.1K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | AWARD | 24,999 | $3.91 | $97.7K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | DISPOSED | 24,999 | $6.60 | $164.9K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| Martin Patricia A. | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | AWARD | 11,463 | $3.91 | $44.8K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | DISPOSED | 11,463 | $18.24 | $209.1K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| FitzPatrick Margaret M | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | AWARD | 24,999 | $3.91 | $97.7K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | DISPOSED | 24,999 | $6.60 | $164.9K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| Wong Stephanie | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | AWARD | 99,999 | $3.91 | $391.0K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | DISPOSED | 99,999 | $6.60 | $659.6K | Form 4 |
| Zakrzewski Joseph S | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Eizen Joshua M | See Remarks | Mar 19, 2026 | AWARD | 92,000 | $3.91 | $359.7K | Form 4 |
| Eizen Joshua M | See Remarks | Mar 19, 2026 | AWARD | 50,150 | $3.91 | $196.1K | Form 4 |
| Eizen Joshua M | See Remarks | Mar 19, 2026 | DISPOSED | 50,150 | $14.29 | $716.6K | Form 4 |
| Eizen Joshua M | See Remarks | Mar 19, 2026 | DISPOSED | 92,000 | $17.88 | $1.6M | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | AWARD | 16,941 | $3.91 | $66.2K | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | AWARD | 10,362 | $3.91 | $40.5K | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | DISPOSED | 10,362 | $17.28 | $179.1K | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Spigelman Melvin K | director | Mar 19, 2026 | DISPOSED | 16,941 | $9.31 | $157.7K | Form 4 |
| Readnour Robin Shane | director | Mar 19, 2026 | AWARD | 23,742 | $3.91 | $92.8K | Form 4 |
| Readnour Robin Shane | director | Mar 19, 2026 | AWARD | 20,724 | $3.91 | $81.0K | Form 4 |
| Readnour Robin Shane | director | Mar 19, 2026 | DISPOSED | 20,724 | $17.28 | $358.1K | Form 4 |
| Readnour Robin Shane | director | Mar 19, 2026 | DISPOSED | 23,742 | $5.91 | $140.3K | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | AWARD | 267,650 | $3.91 | $1.0M | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | AWARD | 249,999 | $3.91 | $977.5K | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | AWARD | 225,000 | $3.91 | $879.8K | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | DISPOSED | 267,650 | $11.99 | $3.2M | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | DISPOSED | 249,999 | $6.60 | $1.6M | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Mar 19, 2026 | DISPOSED | 225,000 | $17.28 | $3.9M | Form 4 |
| Williams Sarah Joanne | Principal Accounting Officer | Mar 3, 2026 | SELL | 327 | $1.06 | $346.62 | Form 4 |
| Eizen Joshua M | See Remarks | Feb 20, 2026 | AWARD | 50,000 | — | — | Form 4 |
| Eizen Joshua M | See Remarks | Feb 20, 2026 | AWARD | 100,000 | $1.04 | $104.0K | Form 4 |
| Day Lucy | Chief Financial Officer | Feb 20, 2026 | AWARD | 38,000 | — | — | Form 4 |
| Day Lucy | Chief Financial Officer | Feb 20, 2026 | AWARD | 77,000 | $1.04 | $80.1K | Form 4 |
| Williams Sarah Joanne | Principal Accounting Officer | Feb 20, 2026 | AWARD | 48,375 | — | — | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Feb 20, 2026 | AWARD | 112,250 | — | — | Form 4 |
| Easom Eric | director, officer: Chief Executive Officer | Feb 20, 2026 | AWARD | 224,500 | $1.04 | $233.5K | Form 4 |